GENE ONLINE|News &
Opinion
Blog

Pfizer
Trials & Approvals Pfizer
Pfizer’s Bivalent RSV Candidate Demonstrates 85% Efficacy in Phase 3 Trials
2022-08-26
M&A Pfizer
Pfizer Acquires Global Blood Therapeutics and its sickle cell disease expertise for $5.4 billion
2022-08-09
Trials & Approvals Pfizer
Myovant, Pfizer’s Endometriosis Pain Treatment Gets FDA Greenlight
2022-08-08
M&A Pfizer
Pfizer Reportedly in Talks of $5 Billion Global Blood Therapeutics Purchase
2022-08-08
Special Pfizer
Pfizer and Flynn Fined £70 Million in Epilepsy Drug Price Hike Scheme
2022-07-22
COVID-19 FDA
FDA Panel Suggests Redesigning Vaccines to Target Omicron Variants, Pfizer & Sanofi Share Booster Updates
2022-06-29
Trials & Approvals Pneumococcal Vaccine
FDA Blesses Merck’s Pneumococcal Vaccine for Pediatric Use
2022-06-23
Funding Pfizer
Valneva Receives Funding From Pfizer to Develop World’s Only Lyme Disease Vaccine
2022-06-21
Funding Series B Funding
Dren Bio Draws $65 Million, Aiming for Phase 1 of ADCC Lead
2022-06-15
Special ASCO
ASCO 2022: AstraZeneca, Pfizer, Novartis Share Key Data on Breast Cancer Therapeutics
2022-06-07
COVID-19 Antiviral Treatment
Pfizer to Address COVID-19 Reinfection After Paxlovid Treatment
2022-05-19
M&A Pfizer
Pfizer Buys Biohaven For $11.6 Billion, Bags Migraine Asset
2022-05-11
COVID-19 mRNA Vaccine
Good or Bad: The 4th Dose of mRNA COVID Vaccine
2022-04-12
M&A Pfizer
ReViral Acquisition by Pfizer To Enhance Its Respiratory Syncytial Virus Therapeutic Portfolio
2022-04-10
COVID-19 COVID-19 Treatment
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30
1 2 3 4 5 … 9
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top